OphA aneurysm that complicated by OphA occlusion with blindness after endovascular coiling and successfully recanalized by intra-arterial thrombolysis.
Case Report Presentation
A 62-year-old female diagnosed by magnetic resonance angiography (MRA) in 2007 to have a right OphA aneurysm measuring about 5 mm in diameter. Follow-up MRA in 2015 showed enlargement of the aneurysm. Catheter angiography was performed and demonstrated asymptomatic increase in size of right OphA aneurysm to measure 6.9 × 5.9 × 4.6 mm with wide neck measuring 6 mm and denoted that the right OphA was originating from the body of the aneurysm (Fig. 1 ).
Intervention
Therapeutic decision was reached through multidisciplinary deliberation of both neurosurgeons and nonsurgical neurointerventionalists, and informed consent was obtained from the patient and her family. Balloon-assisted coiling was elected to attempt dense packing of the wide necked aneurysm. A 75 mg of clopidogrel and a 100 mg of aspirin were administered 4 days before the procedure. After general anesthesia and femoral puncture, systemic heparinization was started with a loading dose of 5,000 units and maintained with a dose of 1,000 units hourly and the activated clotting time (ACT) kept above 250 s throughout the procedure. The right femoral artery was used to place a 6F guiding catheter (Fubuki; ASAHI-INTECC, Aichi, Japan) indwelled into the right cervical ICA. Excelsior SL-10 microcatheter (Stryker, Kalamazoo, MI, USA) and one balloon catheter (4 × 10 mm Scepter C balloon; Microvention, Tustin, CA, USA) were then positioned in the ICA clinoid segment. Balloon test occlusion (BTO) of the OphA was performed using Scepter C balloon inflated in the right ICA at the aneurysm neck, and then we performed cerebral angiography through the guiding catheter, which demonstrated right OphA reconstitution with a retinochoroidal blush through retrograde flow from the frontal branch of the right superficial temporal artery (Fig. 2) .
The aneurysm was packed with coils and the last right ICA angiography showed patency of the right OphA and intraaneurysmal body filling. The heparin was reversed with protamine sulfate, and immediately after the procedure, the
Introduction
Endovascular treatment of the internal carotid artery (ICA) paraclinoid aneurysms has been proposed as an alternative to surgical clipping. [1] [2] [3] [4] [5] Nevertheless, the risk of impaired vision due to unexpected thromboembolism or occlusion of the ophthalmic artery (OphA) after coiling is still a major concern. [6] [7] [8] Incidence of new visual deficits in paraophthalmic aneurysms treated surgically ranged from 4.8 to 7.5%. 9, 10) The neurointerventional therapies have done little to reduce these risks as the incidence of visual complications following endovascular coiling of paraophthalmic aneurysms are estimated to be approximately 5%. 7, 10, 11) Rouchaud et al. found that the coverage of the OphA by flow diverters is not a harmless treatment because 17.9% of patients had permanent ophthalmic complications. These complications can be mild or severe, but some are only detected with a complete and extensive ophthalmic examination, which was not performed in most previous studies.
12 ) We present a case of an the right OphA. The right external carotid artery (ECA) angiography revealed the disappearance of the retinochoroidal blush as seen in the OphA BTO. These findings suggested thromboembolic event occurring through the right OphA (Fig. 3) . Endovascular procedure for the right OphA occlusion was performed under local anesthesia and systemic heparinization which started with a loading dose of 5,000 units and was maintained with a dose of 1,000 units hourly keeping the ACT above 300 s. A 6F-guiding catheter placed into the right cervical ICA and a carnelian PIXIE (Tokai Medical Products, Aichi, Japan) with its distal tip placed close to the orifice of the right OphA confirmed by selective angiography. Mechanical disruption of the thrombus using a micro-guidewire and local intra-arterial fibrinolysis (LIF) using 1,20,000 units Urokinase was performed with evident recanalization of the OphA with a normal anterograde flow until the third segment (Fig. 4) . At the same time the visual acuity of the right eye was improving until the patient restore normal vision through. Heparin reverse was not carried out the final ACT was 238 s. Postoperative systemic heparinization was continued for 48 h. Dual antiplatelet therapy was continued 6 months after the procedure.
Follow-up finding
The patient maintained normal visual acuity and the fundus photograph showed no ischemic lesion in her right retina.
Discussion
Periprocedural thromboembolic complications from endovascular treatment of intracranial aneurysms are estimated to occur in 2-15% of patients. 13) Aggressive treatment of acute intraprocedural thrombus formation with intra-arterial or intravenous administration of fibrinolytics patient had no neurological deficit, and the patient was transferred to the recovery room.
Fifteen minutes later, the patient complained from blurred vision in her right eye. Although continuous heparin infusion was started, her visual disturbance progressed rapidly to complete blindness and total loss of light reflex in about 1 h after the endovascular procedure. The patient transferred emergently for cerebral angiography which demonstrated the complete occlusion of not only the treated aneurysm but also or glycoprotein IIb/IIIa (GpIIb/IIIa) inhibitors has become a standard treatment for these complications. Recanalization of the treated artery is usually essential to avoid permanent neurological deficit. 13) Unfavorable aneurysmal configurations, including wide-neck lesions and those in which OphA entry is incorporated into the aneurysmal neck or the related ophthalmologic morbidities constitute a persistent challenge for endovascular coiling of OphA aneurysms. 14) BTO seems helpful in planning treatment strategies for coiling of OphA aneurysms that preserve vision.
3) Collateral channels between the branches of the ECA and OphA prevent permanent blindness after the occlusion of the OphA in 90% of patients. 15, 16) Thrombotic occlusion at the OphA orifice is a major concern during the coil embolization procedure itself and in the follow-up period. 17) Although the probability of patent collaterals is high, however, the potential risk of ocular ischemia after coiling cannot be ignored. 17) Anterograde ophthalmic flow can be obliterated by thromboembolism during coil embolization without direct coil protrusion into the orifice of the OphA. Acknowledgment that tiny thrombi can occlude the central retinal artery regardless of the collateral flow, prompt handling of unexpected thromboembolic complications is vital to salvage visual function. 18) Visual prognosis in patients with central retinal artery occlusion (CRAO) has been reported to be very poor, because up to 92% have permanent loss of vision, with a final visual acuity of counting fingers of less. [19] [20] [21] [22] [23] [24] [25] [26] Visual acuity at the time of initial presentation ranges from counting fingers to light perception in 74-90% of eyes. 21, 26) Conventional treatment modalities for CRAO include ocular massage, anterior chamber paracentesis, intraocular pressurelowering agents (e.g., mannitol, acetazolamide, and topical agents), hyperbaric oxygen, anticoagulants, and hemodilution, although efficacy regarding visual outcome of these treatments have not been clearly proved. 19) Several case series 27, 28, 29) and a meta-analysis 30) indicated that LIF may improve visual outcome in patients with CRAO. Potential side effects of LIF include hemorrhagic or ischemic complication of the brain. For this reason, the benefit of LIF has also not generally been widely reported. Arnold et al. 19) proved the efficacy of LIF for the acute CRAO within 6 h after the onset compared with conventional therapy. They injected Urokinase, in a dose ranging from 1,00,000 units to 10,00,000 units (mean dose 6,77,000 units) manually through a microcatheter placed in the proximal segment of the OphA. Prospective randomized multicenter clinical trial in Europe to compare treatment outcome after conservative standard treatment with LIF using recombinant tissue plasminogen activator for patients with CRAO within 20 h after the onset was stopped after the first interim analysis because of apparently similar efficacy and the higher rate of adverse reactions in LIF group. 31) These data suggest that LIF for CRAO should be performed by skilled neurointerventionalists as soon as possible after the onset.
In our case, the BTO revealed intact collateral circulation between the ECA and OphA and the immediate post-coiling angiography showed preserved anterograde flow of the OphA. However, rapid reverse of systemic heparinization by protamine sulfate might induce progressing thrombosis in coiled intraaneurysmal sac, which involved in the origin of the right OphA. The progressing thrombosis reached the third segment of the OphA, and that is the reason the collateral flow from the ECA could not work. The patient suffered from complete visual loss in the right eye. Urokinase infusion through the microcatheter placed in the origin of the right OphA successfully dissolved the thrombus and made the OphA recanalized. The patient's visual acuity completely recovered.
Conclusion
We need to highlight that during endovascular coiling of the OphA aneurysm the risk of visual loss due to thromboembolic complications cannot be ignored despite good retrograde flow during OphA occlusion test by a balloon catheter. Rapid endovascular intervention is required for recovering of visual disturbance in such a situation.
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